Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Chronic inflammation in polycystic ovary syndrome (PCOS) may be the result of dysregulation of cytokine production (due to insulin resistance, excess visceral fat and hyperandrogenemia), i.e., overproduction of pro-inflammatory factors (e.g. TNF, IL-1, IL-6) in relation to anti-inflammatory ones (IL-10). This condition may be an important link between obesity and insulin resistance, which is crucial in the etiopathogenesis of the syndrome. However, it is not known whether it results from the tendency to accumulate adipose tissue or is a feature of the syndrome itself. Concomitant endocrinopathies, i.e. obesity, dyslipidemia, insulin resistance, diabetes and thyroid diseases, may additionally influence the activity of chronic inflammation. There is no data indicating the relationship between chronic inflammation and PCOS phenotypes, the severity of metabolic disorders, ovarian reserve and the influence of thyroid function on its activity in PCOS.
The aim of the study is:
i) to assess and compare serum concentrations of selected inflammatory markers (leucocytosis, CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha) in women with different phenotypes PCOS and hypothalamic-pituitary-ovarian axis dysfunction (HPOD) (control), ii) to evaluate the impact of subclinical hypothyroidism (defined as TSH>2.5 uIU/ml, fT3 3,1-6,80 pmol/l, fT4 12,0-22,0 pmol/l), with the presence and absence of circulating antithyroid antibodies (a-TPO and a-TG), on the balance between anti- and pro-inflammatory factors in women with different PCOS and HPOD phenotypes, iii) to assess the impact of imbalance between anti- and pro-inflammatory factors in women with different PCOS and HPOD phenotypes on ovarian reserve indices, expressed as FSH and AMH concentrations.
The study population will be characterized in terms of demographic (age, BMI), gynecological (age of first and last menstrual period, cycle length, history of reproductive organ surgeries, ultrasound measurements of endometrial width, ovarian volume) and obstetrics (pregnancies, childbirth, miscarriages) data. PCOS syndrome (and its phenotypes) will be recognized by the Rotterdam criteria. HPOD will be diagnosed according to WHO criteria. During hospitalization, blood samples will be collected for scheduled analyzes (30 ml of blood in total).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Polycystic ovary syndrome (PCOS) | Active Comparator | Women meeting the Rotterdam-ESHRE-ASRM criteria for a diagnosis of PCOS |
|
| Hypothalamic-Pituitary-Ovarian Axis Dysfunction (HPOD) | Active Comparator | Women meeting the WHO criteria for a diagnosis of HPOD |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Measurement and comparison of leucocytosis and concentrations of CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha in both study arms | Diagnostic Test | A venous blood sample of approximately 10 ml will be collected in the morning after 8 hours of fasting to determine and compare the above parameters of peripheral blood in both arms of the study |
| Measure | Description | Time Frame |
|---|---|---|
| Values of inflammation parameters - leukocytosis in peripheral blood in both study arms | Measurement and comparison of leukocyte count (n/µL) in peripheral blood in both study arms | up to 6 months |
| Values of inflammation parameters - CRP in peripheral blood in both study arms | Measurement and comparison of concentrations of CRP (mg/l) in peripheral blood in both study arms | up to 6 months |
| Values of inflammation parameters - procalcitonine in peripheral blood in both study arms | Measurement and comparison of concentrations of procalcitonin (μg/l) in peripheral blood in both study arms | up to 6 months |
| Values of inflammation parameters - fibrinogen in peripheral blood in both study arms | Measurement and comparison of concentrations of procalcitonin fibrinogen (g/l) in peripheral blood in both study arms | up to 6 months |
| Values of inflammation parameters - ferritin in peripheral blood in both study arms | Measurement and comparison of concentrations of procalcitonin ferritin (μg/l) in peripheral blood in both study arms | up to 6 months |
| Values of inflammation parameters - IL-1 in peripheral blood in both study arms | Measurement and comparison of concentrations of procalcitonin IL-1 (pg/ml) in peripheral blood in both study arms | up to 6 months |
| Values of inflammation parameters - IL-6 in peripheral blood in both study arms |
| Measure | Description | Time Frame |
|---|---|---|
| Correlation between the concentration of TSH (mIU/l) and the parameters of inflammation - leukocytosis in both arms of the study | Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: leukocyte count (n/µL) | up to 6 months |
| Correlation between the concentration of TSH (mIU/l) and the parameters of inflammation - CRP in both arms of the study |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Robert Jach, Prof., Ph.D. | Jagiellonian University | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Jagiellonian University Medical College, Department of Gynecology and Obstetrics | Krakow | 31-501 | Poland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
prospective tertiary single-centre cohort study
Not provided
Not provided
Not provided
Not provided
|
| Evaluation of the impact of subclinical hypothyroidism, with present/ absent antithyroid antibodies, on the balance between anti- and pro-inflammatory factors in women in both study arms | Diagnostic Test | A venous blood sample of approximately 10 ml will be collected in the morning after 8 hours of fasting to determine and compare blood levels of leukocytosis, CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha depending on the blood concentrations of TSH, a-TPO and a-TG in women in both study arms |
|
| Assessment of the impact of imbalance between anti- and pro-inflammatory factors in women with different PCOS and HPOD phenotypes on ovarian reserve indices | Diagnostic Test | A venous blood sample of approximately 10 ml will be collected in the morning after 8 hours of fasting to determine and compare blood levels of leukocytosis, CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha and AMH, FSH in women in both study arms |
|
Measurement and comparison of concentrations of procalcitonin IL-6 (pg/ml) in peripheral blood in both study arms |
| up to 6 months |
| Values of inflammation parameters - IL-10 in peripheral blood in both study arms | Measurement and comparison of concentrations of procalcitonin IL-10 (pg/ml) in peripheral blood in both study arms | up to 6 months |
| Values of inflammation parameters - TNF-alpha in peripheral blood in both study arms | Measurement and comparison of concentrations of procalcitonin TNF-alpha (pg/ml) in peripheral blood in both study arms | up to 6 months |
Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: CRP (mg/l) |
| up to 6 months |
| Correlation between the concentration of TSH (mIU/l) and the parameters of inflammation - procalcitonin in both arms of the study | Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: procalcitonin (μg/l) | up to 6 months |
| Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: fibrinogen (μg/l) | Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: fibrinogen (g/l) | up to 6 months |
| Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: ferritin (μg/l) | Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: ferritin (μg/l) | up to 6 months |
| Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: il-1 | Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: iL-1 (pg/ml) | up to 6 months |
| Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: il-6 | Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: iL-6 (pg/ml) | up to 6 months |
| Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: il-10 | Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: iL-10 (pg/ml) | up to 6 months |
| Correlation between the concentration of TSH (mIU/l) and inflammatory parameters: TNF-alpha | Evaluation of the correlation between the concentration of TSH (mIU/l) and inflammatory parameters: TNF-alpha (pg/ml) | up to 6 months |
| Correlation between the concentration of a-TPO (IU/ml) and the parameters of inflammation - leukocytosis in both arms of the study | Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: leukocyte count (n/µL) | up to 6 months |
| Correlation between the concentration of a-TPO (IU/ml) and the parameters of inflammation - CRP in both arms of the study | Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: CRP (mg/l) | up to 6 months |
| Correlation between the concentration of a-TPO (IU/ml) and the parameters of inflammation - procalcitonin in both arms of the study | Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: procalcitonin (μg/l) | up to 6 months |
| Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: fibrinogen (μg/l) | Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: fibrinogen (μg/l) | up to 6 months |
| Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: ferritin (μg/l) | Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: ferritin (μg/l) | up to 6 months |
| Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-1 (pg/ml) | Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-1 (pg/ml) | up to 6 months |
| Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-6 (pg/ml) | Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-6 (pg/ml) | up to 6 months |
| Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-10 (pg/ml) | Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: il-10 (pg/ml) | up to 6 months |
| Correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: TNF-alpha (pg/ml) | Evaluation of the correlation between the concentration of a-TPO (IU/ml) and inflammatory parameters: TNF -alpha (pg/ml) | up to 6 months |
| Correlation between the concentration of a-TG (IU/ml) and the parameters of inflammation - CRP in both arms of the study | Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: CRP (mg/l) | up to 6 months |
| Correlation between the concentration of a-TG (IU/ml) and the parameters of inflammation - leukocytosis in both arms of the study | Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: leukocyte count (n/µL) | up to 6 months |
| Correlation between the concentration of a-TG (IU/ml) and the parameters of inflammation - procalcitonin in both arms of the study | Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: procalcitonin (μg/l) | up to 6 months |
| Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: fibrinogen (μg/l) | Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: fibrinogen (μg/l) | up to 6 months |
| Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-1 (pg/ml) | Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-1 (pg/ml) | up to 6 months |
| Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-6 (pg/ml) | Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-6 (pg/ml) | up to 6 months |
| Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-10 (pg/ml) | Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: il-10 (pg/ml) | up to 6 months |
| Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: TNF-alpha (pg/ml) | Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: TNF-alpha (pg/ml) | up to 6 months |
| Correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: ferritin (μg/l) | Evaluation of the correlation between the concentration of a-TG (IU/ml) and inflammatory parameters: ferritin (μg/l) | up to 6 months |
| Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - leukocytosis in both arms of the study | Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: leukocyte count (n/µL) | up to 6 months |
| Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - CRP in both arms of the study | Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: CRP (mg/l) | up to 6 months |
| Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - procalcitonin in both arms of the study | Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: procalcitonin (μg/l) | up to 6 months |
| Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - fibrinogen in both arms of the study | Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: fibrinogen (μg/l) | up to 6 months |
| Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - ferritin in both arms of the study | Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: ferritin (μg/l) | up to 6 months |
| Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - il-1 in both arms of the study | Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: il-1 (pg/ml) | up to 6 months |
| Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - il-6 in both arms of the study | Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: il-6 (pg/ml) | up to 6 months |
| Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - il-10 in both arms of the study | Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: il-10 (pg/ml) | up to 6 months |
| Correlation between the concentration of AMH (pmol/l) and the parameters of inflammation - TNF-alpha in both arms of the study | Evaluation of the correlation between the concentration of AMH (pmol/l) and inflammatory parameters: TNF-alpha (pg/ml) | up to 6 months |
| Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - leukocytosis in both arms of the study | Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: leukocyte count (n/µL) | up to 6 months |
| Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - CRP in both arms of the study | Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: CRP (mg/l) | up to 6 months |
| Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - procalcitonin in both arms of the study | Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: procalcitonin (μg/l) | up to 6 months |
| Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - fibrinogen in both arms of the study | Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: fibrinogen (μg/l) | up to 6 months |
| Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - ferritin in both arms of the study | Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: ferritin (μg/l) | up to 6 months |
| Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - il-1 in both arms of the study | Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: il-1 (pg/ml) | up to 6 months |
| Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - il-6 in both arms of the study | Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: il-6 (pg/ml) | up to 6 months |
| Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - il-10 in both arms of the study | Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters: il-10 (pg/ml) | up to 6 months |
| Correlation between the concentration of FSH (IU/l) and the parameters of inflammation - TNF-alpha in both arms of the study | Evaluation of the correlation between the concentration of FSH (IU/l) and inflammatory parameters:TNF-alpha (pg/ml) | up to 6 months |
| ID | Term |
|---|---|
| D011085 | Polycystic Ovary Syndrome |
| ID | Term |
|---|---|
| D010048 | Ovarian Cysts |
| D003560 | Cysts |
| D009369 | Neoplasms |
| D010049 | Ovarian Diseases |
| D000291 | Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D006058 | Gonadal Disorders |
| D004700 | Endocrine System Diseases |
Not provided
Not provided